ARCHIVES

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

ASCO, NCCS Call For Oncology Center

September 13, 2002

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

AACR Honors Scientists: Opens Web Sites

May 10, 1996

Funding opportunities listed.

November 5, 2004

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008